📊 Statistics
- Analyst 1 Year Price Target:
-
- Upside/Downside from Analyst Target:
-
- Broker Call:
-
- Dividend Minimum 3 Year Yield:
0.00%
- EPS Growth Range (1Y):
-
- Net Income Growth Range (1Y):
-
- Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 SGX Earnings Announcements for TID
| Date of Broadcast |
Title |
Financial Year Ended |
Xtrackers MSCI China UCITS ETF 1C (TID)
Market: SGX |
Currency: SGD
Address:
📈 Xtrackers MSCI China UCITS ETF 1C Historical Chart
🧾 Recent Financial Statement Analysis
📰 Related News & Research
Showing results matched by any of: TID, Xtrackers MSCI China UCITS ETF 1C
January 4, 2026
Suzhou Ribo Life Science Co., Ltd. IPO: Investor Analysis & Outlook Suzhou Ribo Life Science Co., Ltd. Date of prospectus: December 31, 2025 Suzhou Ribo Life Science IPO: In-Depth Analysis, Investor Insights & Listing Outlook IPO Snapshot: Key Offer Terms…
June 29, 2025
1. IPO Details Purpose of IPOMedtide plans to raise up to HKD 514 million (~USD 65.5 million), with proceeds allocated as follows: 76.4% for new peptide and oligonucleotide production facilities in the U.S. and China (including a Rocklin, California site), 9.5% to expand…
